Skip to main content
. Author manuscript; available in PMC: 2013 Oct 1.
Published in final edited form as: J Immunol. 2012 Aug 29;189(7):3404–3410. doi: 10.4049/jimmunol.1201138

Figure 4. Effect of HSP65 on OVA-pulsed BMDC function following transfer into previously sensitized and challenged mice.

Figure 4

The in vivo effects of HSP65 on OVA-pulsed BMDCs were determined. All groups of mice were sensitized to OVA followed by primary OVA challenge. Two weeks after primary OVA challenge, mice received (intratracheal instillation) BMDCs pretreated with HSP65 and pulsed with OVA (OVA/HSP65) or PBS as control (PBS/HSP65), or pretreated with vehicle and pulsed with OVA (OVA/vehicle) or pulsed with PBS (PBS/vehicle). (A) Changes in airway resistance (RL). (B) Cell composition in BAL fluid. (n=8). * p<0.05 compared to OVA/vehicle.